Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

Open Label Extension Safety and Efficacy Study of TNX-102 SL Tablets in Military Related PTSD and Related Conditions

ClinicalTrials.gov ID: NCT02421679

Public ClinicalTrials.gov record NCT02421679. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 21, 2026, 9:30 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A 12-Week, Open-Label, Multicenter, Extension Study To TNX-CY-P201 To Evaluate The Safety And Efficacy Of TNX-102 SL Taken Daily At Bedtime In Patients With Military-Related PTSD And Related Conditions

Study identification

NCT ID
NCT02421679
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Tonix Pharmaceuticals, Inc.
Industry
Enrollment
159 participants

Conditions and interventions

Conditions

Interventions

  • TNX-102 SL Drug

Drug

Eligibility (public fields only)

Age range
18 Years to 65 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Apr 13, 2015
Primary completion
May 25, 2016
Completion
May 25, 2016
Last update posted
Feb 5, 2025

2015 – 2016

United States locations

U.S. sites
22
U.S. states
13
U.S. cities
22
Facility City State ZIP Site status
Tuscaloosa VA Medical Center Tuscaloosa Alabama 35404
Noesis Pharma Phoenix Arizona 85032
Sun Valley Research Center Imperial California 92251
Synergy Clinical Research National City California 91950
Excell Research, Inc Oceanside California 92506
Neuropsychiatric Research Center of Orange County Orange California 92868
CITRIALS Riverside California 92506
CESAMH San Diego California 92103
Cns, Inc. Torrance California 90502
Sarkis Clinical Trials Lake City Florida 32025
Compass Research North, LLC Leesburg Florida 34748
Clinical Neuroscience Solutions, Inc. Orlando Florida 32801
Atlanta Center For Medical Research Atlanta Georgia 30308
Great Lakes Clinical Trials Chicago Illinois 60640
Novex Clinical Research New Bedford Massachusetts 02740
Premier Psychiatric Research Institute, Inc. Lincoln Nebraska 68526
Altea Research Las Vegas Nevada 89102
Neurobehavioral Research, Inc. Cedarhurst New York 11516
University of Cincinnati College of Medicine Cincinnati Ohio 45219
University Hospitals Case Medical Center Cleveland Ohio 44106
Clinical Trials of Texas San Antonio Texas 78229
Northwest Clinical Research Center Bellevue Washington 98007

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02421679, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Feb 5, 2025 · Synced Jul 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT02421679 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →